These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23665287)
21. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma. Li H; Liu F; Zhu H; Zhou X; Lu J; Chang H; Hu J Med Sci Monit; 2016 Feb; 22():549-53. PubMed ID: 26893439 [TBL] [Abstract][Full Text] [Related]
22. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma. Sawai H; Nishida N; Khor SS; Honda M; Sugiyama M; Baba N; Yamada K; Sawada N; Tsugane S; Koike K; Kondo Y; Yatsuhashi H; Nagaoka S; Taketomi A; Fukai M; Kurosaki M; Izumi N; Kang JH; Murata K; Hino K; Nishina S; Matsumoto A; Tanaka E; Sakamoto N; Ogawa K; Yamamoto K; Tamori A; Yokosuka O; Kanda T; Sakaida I; Itoh Y; Eguchi Y; Oeda S; Mochida S; Yuen MF; Seto WK; Poovorawan Y; Posuwan N; Mizokami M; Tokunaga K Sci Rep; 2018 May; 8(1):7958. PubMed ID: 29784950 [TBL] [Abstract][Full Text] [Related]
23. Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis. Kuang XJ; Mo DC; Qin Y; Ahir BK; Wang JJ; Peng Z; Deng ZL Medicine (Baltimore); 2019 Mar; 98(11):e14767. PubMed ID: 30882647 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes. Zhu H; Wu J; Shen X Scand J Gastroenterol; 2017 Feb; 52(2):209-215. PubMed ID: 27797287 [TBL] [Abstract][Full Text] [Related]
25. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212 [TBL] [Abstract][Full Text] [Related]
26. Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection. Joshita S; Umemura T; Katsuyama Y; Ichikawa Y; Kimura T; Morita S; Kamijo A; Komatsu M; Ichijo T; Matsumoto A; Yoshizawa K; Kamijo N; Ota M; Tanaka E Hum Immunol; 2012 Mar; 73(3):298-300. PubMed ID: 22245236 [TBL] [Abstract][Full Text] [Related]
27. TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals. Degasperi E; Galmozzi E; Facchetti F; Farina E; D'Ambrosio R; Soffredini R; Iavarone M; Lampertico P J Viral Hepat; 2019 Oct; 26(10):1233-1236. PubMed ID: 31177595 [TBL] [Abstract][Full Text] [Related]
28. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234 [TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study. Lee MH; Huang YH; Chen HY; Khor SS; Chang YH; Lin YJ; Jen CL; Lu SN; Yang HI; Nishida N; Sugiyama M; Mizokami M; Yuan Y; L'Italien G; Tokunaga K; Chen CJ; Hepatology; 2018 Feb; 67(2):651-661. PubMed ID: 28921602 [TBL] [Abstract][Full Text] [Related]
30. Association of IL-6 G-174C (rs1800795) variant with the susceptibility to hepatocellular carcinoma in patients with chronic hepatitis. Abuelnadar EH; Ramadan LM; Shahin HE; Alakilli SYM; Wahsh E; El-Beltagy NS; Salem ET; Hatata AS; El-Said AM; Alhelf M J Egypt Natl Canc Inst; 2024 Oct; 36(1):32. PubMed ID: 39428452 [TBL] [Abstract][Full Text] [Related]
31. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia. Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790 [TBL] [Abstract][Full Text] [Related]
32. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma. Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308 [TBL] [Abstract][Full Text] [Related]
33. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282 [TBL] [Abstract][Full Text] [Related]
34. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada. Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234 [TBL] [Abstract][Full Text] [Related]
35. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study. Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449 [TBL] [Abstract][Full Text] [Related]
36. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection. Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552 [TBL] [Abstract][Full Text] [Related]
37. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. Catano G; Kulkarni H; He W; Marconi VC; Agan BK; Landrum M; Anderson S; Delmar J; Telles V; Song L; Castiblanco J; Clark RA; Dolan MJ; Ahuja SK PLoS One; 2008; 3(11):e3636. PubMed ID: 18982067 [TBL] [Abstract][Full Text] [Related]
38. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604 [TBL] [Abstract][Full Text] [Related]
39. Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma. Li Y; Zhai Y; Song Q; Zhang H; Cao P; Ping J; Liu X; Guo B; Liu G; Song J; Zhang Y; Yang A; Yan H; Yang L; Cui Y; Ma Y; Xing J; Shen X; Liu T; Zhang H; An J; Bei JX; Jia W; Kang L; Liu L; Yuan D; Hu Z; Shen H; Lu L; Wang X; Li H; He F; Zhang H; Zhou G Clin Cancer Res; 2018 Feb; 24(4):906-915. PubMed ID: 29246937 [No Abstract] [Full Text] [Related]
40. A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Sharkawy RE; Bayoumi A; Metwally M; Mangia A; Berg T; Romero-Gomez M; Abate ML; Irving WL; Sheridan D; Dore GJ; Spengler U; Lampertico P; Bugianesi E; Weltman M; Mollison L; Cheng W; Riordan S; Santoro R; Gallego-Durán R; Fischer J; Nattermann J; D'Ambrosio R; McLeod D; Powell E; Latchoumanin O; Thabet K; Najim MAM; Douglas MW; Liddle C; Qiao L; George J; Eslam M; Sci Rep; 2019 Feb; 9(1):1439. PubMed ID: 30723271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]